Chimeric antigen receptor T cells (CAR-T): Recent studies of HCC tumor xenografts in mice and in vitro demonstrated that engineered CAR-T cells expressing a GPC3 CAR could eliminate GPC3-positive HCC cells [141,142,143,144]. This evidence concerns the gene GPC3 and neoplasm.